Cargando…
Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
The novel coronavirus SARS-CoV-2 emerged in China in 2019 and quickly spread globally, causing a pandemic. There is an urgent need to develop vaccines against the virus, and both convalescent plasma and immune globulin are currently in clinical trials for treatment of patients with COVID-19. It is u...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872068/ https://www.ncbi.nlm.nih.gov/pubmed/32678695 http://dx.doi.org/10.1080/21645515.2020.1787074 |